Call toll-free 800.328.1267
[showmodule id=”58959″]
Everyone’s been focused on the selloff in tech, but something more bullish may be happening in a forgotten corner of the market.
Large pharmaceutical companies including Pfizer (PFE), Merck (MRK) and Amgen (AMGN) have formed triangles in recent weeks. The consolidation comes at a time when money seems to be shifting toward large health-care names.
PFE ripped to new multiyear highs between July and early October. Since then it’s chopped in an increasingly tight range with lower highs and higher lows. That kind of sideways triangle is sometimes viewed as a consolidation pattern before a move.
Pfizer (PFE) chart with potential triangle and 50-day moving average.
This time there could be historical relevance because PFE is challenging old highs from November 2001. Is there potential for a long-term breakout?
MRK is also pushing a levels from early this century. Its price action is more bullish because it’s made higher lows while bucking resistance at $76. Chart watchers may consider that an “ascending triangle” with the potential for continued upside.
Merck (MRK) with ascending triangle and 50-day moving average.
AMGN has a similar pattern, making higher lows as it knocks against $198.
By the way, all three companies reported earnings last month. MRK initially dropped after missing estimates and PFE got some negative commentary from its mediocre revenue. AMGN seemed to have the most positive results.
In conclusion, rotation away from technology has been a key theme in the fourth quarter. But money needs to go somewhere, and these chart patterns suggest some of it could be migrating to big health-care names.
Amgen (AMGN) with ascending triangle.
Stocks are pulling back as traders wait for key inflation data and the start of earnings season. The S&P 500 fell 1.5 percent in the holiday-shortened period between Friday, December 29, and Friday, January 5. It was the first drop in 10 weeks, ending the index's...
Merck surged in late 2022 and consolidated during the first quarter. Now the drug maker could be breaking out. The first pattern on today’s chart is the rally between mid-October and early January, which included a breakout to new record highs. MRK then pulled back...
Diabetes company DexCom has been fighting higher since June, and now it may be interesting to trend followers. The first pattern on today’s chart is the pair of bullish gaps last month. The initial rally came after the Centers for Medicare and Medicaid Services...